ÎÚÑ»´«Ã½

Nikos Pavlidis is the worldwide president of Diagnostic Solutions within the BD Life Sciences segment. He focuses on both the execution of the long-term strategy as well as the achievement of short-term business goals for the molecular diagnostics, microbiology, and point-of-care platforms.

Nikos joined BD more than 25 years ago and has held various customer support, sales, and marketing roles within Europe, including leading the BD IDS commercial organizations across Northwest Europe. 

In 2013, Nikos joined the Global BD IDS organization and relocated to the division’s global headquarters in Sparks, Maryland. From 2018 to 2021, he led BD IDS efforts surrounding inclusion and diversity and drove initiatives that fostered programs around conscious inclusion, as well as internal talent development and acquisition. 

Having dedicated more than two decades working closely with healthcare professionals, Nikos understands the value and impact of diagnostics in clinical decision-making in high- and mid-throughput labs and the shift to non-traditional care settings, including home and retail locations. He strongly believes that broader assay menus, combination testing, and self-collection will improve access to diagnostics and help address health inequities in diagnosis and treatment, which may reduce the burden of disease through earlier, more accurate diagnosis and the guided use of antibiotics.

Nikos serves on the University of Maryland Foundation Board of Trustees and holds a bachelor’s degree in biomedical engineering from the University of Athens, Greece, and an MSc in biomedical engineering from the University of Dundee, UK.